Seagen acquisition will give Pfizer ' anchor asset ' Wall Street desires: Pfizer CEO Bourla

has been actively dealmaking and receiving FDA approvals for new products and new indications in the past couple of years, but that has all been overshadowed by its runaway success with COVID-19 products resulting in tens of billions in the past few years. The company reported earnings Tuesday,…#fda #jpmorgan #pfizer #albertbourla #seagen #adctechnology #yahoofinance #mylotarg #holds #anjaleekhemlani
Source: Reuters: Health - Category: Consumer Health News Source Type: news